Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab

Abstract Background To investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly with ranibizumab. Methods We retrospectively analyzed the medical records of all patients who received intravitreal ranibizumab (IVR) trea...

Full description

Bibliographic Details
Main Authors: Yuxiang Hu, Yi Cheng, Xiaoxuan Xu, Bo Yang, Feng Mei, Qiong Zhou, Li Yan, Jun Wang, Xiaorong Wu
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Ophthalmology
Subjects:
Diabetic retinopathy
Macular edema
Neutrophil–lymphocyte ratio
Predictors
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12886-019-1200-4

Internet

http://link.springer.com/article/10.1186/s12886-019-1200-4

Similar Items